Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New tuberculosis study results from St. Louis University described
December 10th, 2008
"Mycobacterium tuberculosis and Mycobacterium bovis bacillus Calmette-Guerin (BCG) induce potent expansions of human memory V gamma V-+(9)delta(+)(2) T cells capable of IFN-gamma production, cytolytic activity, and mycobacterial growth inhibition. Certain phosphoantigens expressed by mycobacteria can stimulate gamma(9)delta(2) T cell expansions, suggesting that purified or synthetic forms of these phosphoantigens may be useful alone or as components of new vaccines or immunotherapeutics," researchers in the United States report. "However, we show that while mycobacteria-activated gamma(9)delta(2) T cells potently inhibit intracellular mycobacterial growth,...
Source: Vaccine Weekly (2008-12-10)
|
